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Mitophagy is an important mechanism in mitochondrial quality control through autophagic
clearance of damaged mitochondria and has been considered to assume protective roles against
some diseases, especially neurodegeneration, including Parkinson’s disease (Haelterman et al.,
2014), and Alzheimer’s disease (Ye et al., 2015). To understand the role of mitophagy in these
diseases, measures to assess mitophagy are of great importance. Among those established methods,
engulfment of mitochondria by autophagosome shown by transmission electron microscope
(TEM) provides unequivocal evidence of occurrence of mitophagy (Klionsky et al., 2012). However,
it demands painstaking effort and is difficult to quantify mitophagy.
MitoTracker has emerged as a useful tool in evaluating mitophagy. Mitochondrial potential-
independent MitoTracker is able to stain live mitochondria and enables demonstration of
colocalization of mitochondria and autophagosome or lysosome with the aid of corresponding
marker (Klionsky et al., 2012). Alternatively, since MitotTracker Green has been used to represent
mitochondrial mass (Agnello et al., 2008; Cottet-Rousselle et al., 2011; Zhou et al., 2011) and
a decrease in MitotTracker intensity may indicate the degradation of mitochondria, it has been
widely utilized to evaluate mitophagy (Kundu et al., 2008; Valentin-Vega et al., 2012). Recently, a
flow cytometry-based approach to determine mitophagy by using MitoTracker Deep Red has been
introduced by Mauro-Lizcano et al. (2015).
Despite the promising role of MitoTracker, we would like to highlight potential limitations in
its interpretation as some factors may significantly affect determination of mitochondrial mass by
MitoTracker staining. First, MitoTracker Deep Red is actually amitochondrial potential-dependent
dye though this is usually not highlighted in themanufacturer’s manual. It has been used as an index
for mitochondrial potential (Lugli et al., 2005; Zhou et al., 2011; Greene et al., 2012). Our data also
suggest that the intensity of MitoTracker Deep Red changes along with mitochondrial potential.
Mitochondrial depolarization induced by carbonyl cyanide 3-chlorophenylhydrazone (CCCP)
treatment decreased fluorescence intensity of MitoTracker Deep Red, while starvation induced by
Earle’s Balanced Salt Solution (EBSS) treatment increased fluorescence intensity of MitoTracker
Deep Red (Figure 1A). JC-1 assay utilized in our experiments confirmed that CCCP disrupted
mitochondrial potential and revealed that EBSS treatment caused mitochondrial potential to
increase (Figure 1B), in line with the report that amino acid starvation raised mitochondrial
potential (Johnson et al., 2014). Our data and previous reports suggest that MitoTracker Deep
Red is a mitochondrial potential-dependent dye and therefore should not be used to quantitatively
assess mitophagy. MitoTracker Green has been widely utilized to represent the mitochondrial
mass (Agnello et al., 2008; Cottet-Rousselle et al., 2011; Zhou et al., 2011). Notwithstanding, we
found that EBSS treatment caused increment in the intensity of MitoTracker Green, indicating
MitoTracker Green staining might also be affected by mitochondrial potential (Figure 1C).
Unexpectedly, our data showed that its intensity increased with CCCP treatment which depolarizes
mitochondria (Figure 1C). As CCCP treatment leads to mitochondrial depolarization and reactive
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FIGURE 1 | MitoTracker dyes are affected by mitochondrial potential or ROS. HeLa cells were treated with DMSO, 10 µM CCCP, 5 mM NAM, or 20 µM TBHP
for 2 h or EBSS for 1 h. Cells were harvested and stained with MitoTracker Deep Red (MTDR) (A), JC-1(B), or MitoTracker Green (MTG) (C), followed by flow
cytometric analysis. The ratio of the red to green fluorescence intensity in JC-1 stained cells was used to represent mitochondrial membrane potential. (D) HeLa cells
were treated as in (A) and followed by western blot to examine the levels of mitochondrial proteins from different compartments. (E) HeLa cells were treated with
DMSO, CCCP, or TBHP along with or without 1 mM NAC for 2 h or EBSS with or without 1 mM NAC for 1 h. Cells were then collected and incubated with MTG for
flow cytometric analysis. HeLa cells were incubated with MTDR (F), MTG (G), or JC-1 (H) for 20 min, washed and then followed by treatment as in (A). Cells were
collected and analyzed using flow cytometry. The error bars represent SEM from three independent experiments; at least 10,000 cells were analyzed per experiment.
Statistical significance was assessed by two-tailed Student’s t-test. Asterisks denote a statistically significant difference from control (p < 0.05); NS, not significant
(p > 0.05).
oxygen species (ROS) generation, we speculated that both
may affect MitoTracker Green staining, with ROS generation
induced by CCCP treatment having a more prominent effect
on MitoTracker staining than mitochondrial depolarization.
The surplus might be responsible for the intensity increase
in MitoTracker Green. To test if ROS are able to enhance
MitoTracker Green fluorescence, tert-butyl hydroperoxide
(TBHP), which is organic peroxide, was applied to the cells.
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Indeed, it resulted in modest but significant increment of
MitoTracker Green fluorescence (Figure 1C). Although ROS
have been reported to affect mitochondrial biogenesis, the
result from our western blot experiments did not reveal
any changes in the proteins from different compartments of
mitochondria upon various treatments, including mitophagy
inducer CCCP or nicotinamide (NAM), ROS inducer TBHP and
autophagy inducer EBSS (Figure 1D). Moreover, N-acetyl-L-
cysteine (NAC), a ROS scavenger, was able to reverse CCCP or
TBHP-induced changes in the intensity of MitoTracker Green,
suggesting that the changes caused by CCCP or TBHP are
ROS-related. NAC failed to suppress EBSS induced intensity
increase whichmay be causedmainly by enhancedmitochondrial
potential (Figure 1E). The process of MitoTracker dye specific
labeling mitochondria consists of its enrichment in mitochondria
and its interaction with mitochondria. MitoTracker probes
passively diffuse across the plasma membrane and then
accumulate in active mitochondria in a potential-dependent
manner. Subsequently, it covalently binds the thiol groups
of the cysteine residues of mitochondrial proteins (Chazotte,
2011). It has been claimed that MitoTracker stains mitochondria
independent of mitochondrial potential after its covalent
binding to mitochondria. However, mitophagy inducers, such
as CCCP treatment, usually have to be applied for a relatively
long period to trigger mitophagy. In addition, the activity of
cysteine containing proteins in mitochondria may be affected by
covalent association of MitoTracker to the thiol groups. Hence,
MitoTracker incubation for analysis is usually performed after
mitophagy-related treatments (Mauro-Lizcano et al., 2015).
This procedure makes MitoTracker staining of mitochondria
dependent of mitochondrial potential, as the mitophagy-related
treatments usually interfere with mitochondrial potential,
impeding MitoTracker accumulation in mitochondria. Our
abovementioned data garnered with MitoTracker incubation
after drug treatment demonstrated a close correlation
between MitoTracker fluorescence and mitochondrial
potential. This might be due to the fact that mitochondrial
potential greatly influences enrichment of MitoTracker in
mitochondria.
To further elucidate if mitochondrion-bound MitoTracker
dyes could retain in mitochondria regardless of mitochondrial
potential, experiments were also carried out with MitoTracker
loaded prior to drug treatments. We found that CCCP treatment
reduced fluorescence intensity in both MitoTracker Deep Red
and MitoTracker Green (Figures 1F,G), rather than enhancing
MitoTracker Green fluorescence when the dye was loaded
after drug treatment. Moreover, EBSS treatment also decreased
MitoTracker intensity if the dyes were loaded after treatment.
We reason that the washout of MitoTracker after preincubation
invalidates the capacity of mitochondria to incorporate free
dye. Consistently, mitochondrial potential-dependent dye JC-
1 revealed decrease in mitochondrial potential if the dye was
preloaded and washed prior to EBSS treatment (Figure 1H).
Hence, the washout step after preincubation of MitoTracker
makes it impossible to detect mitochondrial proliferation, which
constitutes an integral part of dynamic mitochondrial biogenesis.
Moreover, MitoTracker Green fluorescence diminished upon
CCCP or EBSS treatment if it was preloaded (Figure 1G),
sharing a similar trend as changes in preloaded JC-1 (Figure 1H).
This indicates that mitochondrion-bound MitoTracker Green is
not linked to mitochondria as tightly as claimed and may be
released off mitochondria like other mitochondrial potential-
dependent dye. Together, our data indicate that MitoTracker
dyes, including MitoTracker Green, are mitochondrial potential-
dependent, and may be affected by ROS level in cells
as well.
Changes in the fluorescence intensity of MitoTracker dyes
can be caused by mitochondrial protein degradation mediated
by mitochondria-derived vesicles (McLelland et al., 2014),
proteasome (Yoshii et al., 2011), or mitochondrial proteases
(Klionsky et al., 2012) in addition to autophagic clearance of
mitochondria. This nonspecificity has been well addressed
by the addition of autophagy inhibitors (Kundu et al., 2008;
Mauro-Lizcano et al., 2015). If autophagy inhibitor is able to
reverse the alterations in MitoTracker, the conclusion that
mitophagy is responsible for the changes should be plausible.
More importantly, a mitochondrial dye utilized to assess
mitophagy entails its specific representing the mitochondrial
mass. In our study, we utilized HeLa cells which have no
detectable endogenous Parkin, an important component for
mitophagy. Therefore, one advantage HeLa cells have over other
cell lines is that drug treatment-induced MitoTracker changes in
these cells will likely be caused by other factors than mitophagy,
though we cannot exclude Parkin-independent mitophagy. In
addition, all the drug treatment lasted for only 2 h, precluding
the possibility of significant mitochondrial biogenesis. Together
with the western blot results, it is convincing that no significant
mitophagy-involved gain or loss of mitochondrial mass occurred
in our study. Instead, the changes in MitoTracker Green or
MitoTracker Deep Red in response to CCCP, EBSS, or TBHP
are related to shift in mitochondrial potential or ROS outburst,
though they are not as pertinent as those detected by the
dyes specifically designed for these aspects, such as JC-1 or
dihydroethidium. Since mitochondrial depolarization and
ROS are intricately implicated in mitophagy, any assay which
may be affected by mitochondrial depolarization or ROS has
its intrinsic defect in evaluating mitophagy. Also, it has been
shown that CCCP may cause redistribution of mitochondrial
dyes, including MTR and MTG, from mitochondria to the
cytosol, and subsequently to lysosome, which is irrelevant
to the engulfment of mitochondria by lysosome (Padman
et al., 2013). It is therefore important to elucidate if
other mitophagy inducers also have similar effect on the
mitochondrial dyes before any such dye is employed to evaluate
mitophagy.
In essence, our data clearly show that currently used
mitochondrial dyes, including MitoTracker Deep Red or
MitoTracker Green, may be affected by mitochondrial
potential or ROS. Taking these limitations into account,
we suggest that quantitative assessment of mitophagy using
MitoTracker should be always interpreted along with other
mitophagy assays. Meanwhile, we await future development
of a more specific marker for precise measurements of
mitophagy.
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